Oral Session 1-10D PTCL: Pathophysiology/Prognosis

[OS1-10D-2] Clinicopathological analysis of BATF3 and IRF4 in PTCL

Joji Shimono¹, Takashi Ishio¹, Hideki Goto¹, Hajime Kobayashi², Akio Shigematsu³, Shuichi Ota³, Yutaka Tsutsumi⁴, Yasutaka Kakinoki⁵, Satoshi Yamamoto⁶, Mitsutoshi Kurosawa⁷, Takeshi Kondo⁸, Hajime Sakai⁹, Takuto Miyagishima¹⁰, Hiroshi Iwasaki¹¹, Yoshihito Haseyama¹², Yasuyuki Kunieda¹³, Takahiro Nagashima¹⁴, Mitsufumi Nishio¹⁵, Satoshi Hashino¹⁶, Yutaka Hatanaka¹⁷, Yoshihiro Matsuno¹⁸, Masao Nakagawa¹, Takanori Teshima¹ (1.Hokkaido University, Hematology, Hokkaido, Sapporo, Japan, 2.Obihiro Kosei Hospital, Hematology, Obihiro, Japan, 3.Sapporo Hokuyu Hospital, Hematology, Sapporo, Japan, 4.Hakodate City Hospital, Hematology, Hakoddate, Japan, 5.Asahikawa City Hospital, Hematology, Asahikawa, Japan, 6.Sapporo City Hospital, Hematology, Sapporo, Japan, 7.Hokkaido Cancer Center, Hematology, Sapporo, Japan, 8.Aiiku Hospital, Hematology, Sapporo, Japan, 9.Teine keijinkai Hospital, Hematology, Sapporo, Japan, 10.Kushiro Rosai Hospital, Hematology, Kushiro, Japan, 11.Sapporo Kosei Hospital, Hematology, Japan, 12.Tonan Hospital, Hematology, Sapporo, Japan, 13.Wakkanai City Hospital, Internal Medicine, Wakkanai, Jaan, 14.Kitami Red Cross Hoapital, Hematology, Kitami, Japan, 15.NTT East Sapporo Hospital, Hematology, Sapporo, Japan, 16.Hokkaido University, Health Care Center, Sapporo, Japan, 17.Hokkaido University, Genome Companion Diagnostics, Sapporo, Japan, 18.Hokkaido Univeristy, Pathilogy, Sapporo, Japan)